HOME >> BIOLOGY >> NEWS
Global warming may cause songbirds to avoid certain foods

KINGSTON, R.I. -- January 26, 2004 -- In yet another example of the far-reaching impact of global warming, a University of Rhode Island student found evidence that suggests some songbirds may avoid eating insects that consume leaves exposed to high levels of carbon dioxide.

URI senior Martina Mller of Kingston, working in cooperation with Associate Professor Scott McWilliams, Ph.D. candidate David Podlesak and colleagues at the University of Wisconsin, studied the food preferences exhibited by black-capped chickadees.

"When plants are grown in conditions of higher carbon dioxide, they produce increased levels of several secondary compounds -- tannins and phenolics -- that they use to defend against herbivory," said the 23-year-old wildlife conservation and biology major. "Those secondary compounds are absorbed by gypsy moth caterpillars that feed on the plant's leaves, which other researchers have found reduces the caterpillar's growth rates. We wanted to see if the chickadees can detect the secondary compounds in the caterpillars and if they have preferences for caterpillars that fed on different types of leaves."

Using chickadees captured in Kingston and acclimated for three days, Mller and McWilliams fed the birds a choice of caterpillars that were high in tannins or phenolics and other caterpillars low in those compounds.

"It was clear that the birds could tell the difference between the different caterpillars and they had strong preferences," Mller said. "They're intelligent birds with a keen capacity to learn."

While the birds showed a distinct preference for caterpillars low in tannins and phenolics, they also showed a preference for foods they had eaten previously. "Previous experience does affect their preferences," Mller said.

So what does all this mean? According to McWilliams, it could mean a great deal in a world that is growing warmer due to increasing levels of carbon dioxide in the atmosphere
'"/>

Contact: Todd McLeish
tmcleish@uri.edu
401-874-7892
University of Rhode Island
26-Jan-2004


Page: 1 2

Related biology news :

1. Global competition closes Texas sawmills/paper mills
2. Global warming and the onward march of the pine
3. Global warming to squeeze western mountains dry by 2050
4. Global wetlands surveyed from space
5. Fourteen Grand Challenges in Global Health announced
6. Global analysis finds a large portion of the earth is still wilderness
7. Global garden grows greener
8. Jane Goodall to receive 2003 Global Environmental Citizen Award
9. Global analysis finds nearly half the Earth is still wilderness
10. Global warming has uneven effect on coastal animals
11. Global aluminium waste headache solved

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Global warming may cause songbirds avoid certain foods

(Date:5/10/2015)... , May 11, 2015 Fingerprint ... sensors FPC1025 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... will be used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK for ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has announced ... Outlook 2020 " report to their offering. ... medicine is expected to have huge marketing potential. Presently, ... the growth of deregulated organs. Several therapeutic molecules are ... form new tissue or sometimes organ transplant is required. ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: